Mycobutin

Mycobutin is a brand name of rifabutin, approved by the FDA in the following formulation(s):

MYCOBUTIN (rifabutin - capsule; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: December 23, 1992
  
  Strength(s): 150MG ^[RLD]

Has a generic version of Mycobutin been approved?

No. There is currently no therapeutically equivalent version of Mycobutin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mycobutin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Mycobutin.

See also...

• Mycobutin Consumer Information (Wolters Kluwer)
• Mycobutin Consumer Information (Cerner Multum)
• Mycobutin Advanced Consumer Information (Micromedex)
• Mycobutin AHFS DI Monographs (ASHP)
• Rifabutin Consumer Information (Wolters Kluwer)
• Rifabutin Consumer Information (Cerner Multum)
• Rifabutin Advanced Consumer Information (Micromedex)
• Rifabutin AHFS DI Monographs (ASHP)